|
- Home | Biogen
Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities
- Company | Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities
- Careers | Biogen
Everyone at Biogen contributes to our mission to create transformative medicines for people who need them the most Explore our business areas to discover where you can make an impact on our team
- Leadership | Biogen
Meet our executive leadership team
- Science Innovation - Biogen
Biogen has pioneered the development of multiple sclerosis treatments for more than 25 years We continue to innovate to advance MS treatment and improve outcomes for patients Our research is focused on potentially transformative therapies, including the potential repair of the damage caused by MS
- Pipeline | Biogen
Biogen is dedicated to addressing challenging diseases by leveraging cutting-edge science and driving an innovative pipeline of potential breakthrough therapies in neurology, immunology, and rare diseases
- Biogen Announces Plans for New Global Headquarters and Innovation Hub . . .
“Nearly 50 years after first putting down roots in Kendall Square, Biogen is embarking on a new chapter in the very heart of the community that has shaped our success,” said Christopher A Viehbacher, President and Chief Executive Officer at Biogen
- Investor Relations | Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities
|
|
|